Renaissance Technologies’s Phio Pharmaceuticals PHIO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2,340
| Closed | -$16K | – | 3986 |
|
2023
Q4 | $16K | Buy |
2,340
+150
| +7% | +$1.03K | ﹤0.01% | 3606 |
|
2023
Q3 | $30K | Buy |
2,190
+937
| +75% | +$12.8K | ﹤0.01% | 3471 |
|
2023
Q2 | $32K | Sell |
1,253
-334
| -21% | -$8.53K | ﹤0.01% | 3694 |
|
2023
Q1 | $80K | Buy |
1,587
+43
| +3% | +$2.17K | ﹤0.01% | 3553 |
|
2022
Q4 | $62K | Sell |
1,544
-434
| -22% | -$17.4K | ﹤0.01% | 3754 |
|
2022
Q3 | $122K | Sell |
1,978
-197
| -9% | -$12.2K | ﹤0.01% | 3530 |
|
2022
Q2 | $165K | Buy |
2,175
+1,791
| +466% | +$136K | ﹤0.01% | 3719 |
|
2022
Q1 | $37K | Buy |
384
+290
| +309% | +$27.9K | ﹤0.01% | 3947 |
|
2021
Q4 | $10K | Buy |
+94
| New | +$10K | ﹤0.01% | 3856 |
|
2020
Q4 | – | Sell |
-188
| Closed | -$43K | – | 3641 |
|
2020
Q3 | $43K | Sell |
188
-499
| -73% | -$114K | ﹤0.01% | 3291 |
|
2020
Q2 | $162K | Buy |
687
+306
| +80% | +$72.2K | ﹤0.01% | 3199 |
|
2020
Q1 | $73K | Buy |
381
+325
| +580% | +$62.3K | ﹤0.01% | 3278 |
|
2019
Q4 | $57K | Buy |
56
+48
| +600% | +$48.9K | ﹤0.01% | 3380 |
|
2019
Q3 | $13K | Buy |
8
+5
| +167% | +$8.13K | ﹤0.01% | 3387 |
|
2019
Q2 | $6K | Buy |
3
+1
| +50% | +$2K | ﹤0.01% | 3512 |
|
2019
Q1 | $5K | Buy |
+2
| New | +$5K | ﹤0.01% | 3413 |
|
2017
Q1 | – | Sell |
-4
| Closed | -$164K | – | 3366 |
|
2016
Q4 | $164K | Buy |
4
+1
| +33% | +$41K | ﹤0.01% | 3037 |
|
2016
Q3 | $336K | Buy |
3
+1
| +50% | +$112K | ﹤0.01% | 2928 |
|
2016
Q2 | $342K | Hold |
2
| – | – | ﹤0.01% | 2910 |
|
2016
Q1 | $257K | Buy |
2
+1
| +100% | +$129K | ﹤0.01% | 3018 |
|
2015
Q4 | $298K | Hold |
1
| – | – | ﹤0.01% | 2886 |
|
2015
Q3 | $215K | Hold |
1
| – | – | ﹤0.01% | 2883 |
|
2015
Q2 | $248K | Buy |
+1
| New | +$248K | ﹤0.01% | 2936 |
|
2015
Q1 | – | Hold |
0
| – | – | – | 3121 |
|